newsfilter
← Latest News
GlobeNewswire·

I-Mab to Participate in the H.C. Wainwright "HCW@Home" Series

ROCKVILLE, Md., June 03, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer,